LOGC

LogicBio Therapeutics, Inc. Common Stock
LOGC

Overview Fund Activity
Delisted

LOGC was delisted on the 15th of November, 2022.

Back to rankings

46 hedge funds and large institutions have $8.66M invested in LogicBio Therapeutics, Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 14 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
46
Holders Change
-11
Holders Change %
-19.3%
% of All Funds
0.73%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
6
Reduced
14
Closed
14
Calls
$14K
Puts
–
Net Calls
+$14K
Net Calls Change
+$41K

Top Buyers

1
Renaissance Technologies
1
Renaissance Technologies
New York
$312K
2
VF
2
Virtu Financial
New York
$49K
3
Acadian Asset Management
3
Acadian Asset Management
Massachusetts
$32K
4
Bank Julius Baer & Co
4
Bank Julius Baer & Co
Switzerland
$13K
5
FT
5
Fiduciary Trust
Massachusetts
$33K

Top Sellers

1
SC
1
Samlyn Capital
New York
$0
2
PIM
2
Platinum Investment Management
Australia
$0
3
EP
3
Eversept Partners
New York
$0
4
PVI
4
Pura Vida Investments
New York
$0
5
Franklin Resources
5
Franklin Resources
California
$621K
Name Holding Trade Value Shares
Change 		Shares
Change %
Walleye Capital
51
Walleye Capital
New York
– -$25K -10,924 Closed
Simplex Trading
52
Simplex Trading
Illinois
– -$22K -9,686 Closed
UBS Group
53
UBS Group
Switzerland
– -$17K -7,561 Closed
JPMorgan Chase & Co
54
JPMorgan Chase & Co
New York
– -$1K -344 Closed
1 2
3